No Record Found
Sector
PharmaceuticalsOpen
₹42.9Prev. Close
₹42.09Turnover(Lac.)
₹16.72Day's High
₹43Day's Low
₹41.9552 Week's High
₹92.8152 Week's Low
₹40.76Book Value
₹23.19Face Value
₹2Mkt Cap (₹ Cr.)
237.06P/E
95.66EPS
0.44Divi. Yield
029 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
30 May 2025
12:00 AM
AGM
Announcement Date: 30 May, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 11.04 | 14.67 | 20.48 | 10 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 116.81 | 106.88 | 71.63 | 47.91 |
Net Worth | 127.85 | 121.55 | 92.11 | 57.91 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 101.29 | 86.87 | 45.63 | 0 |
yoy growth (%) | 16.59 | 90.37 | 0 | 0 |
Raw materials | -76.91 | -63.32 | -33.57 | 0 |
As % of sales | 75.93 | 72.89 | 73.58 | 0 |
Employee costs | -2.89 | -1.94 | -1.76 | -0.15 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 19.69 | 20.59 | 9.26 | -0.76 |
Depreciation | -0.25 | -0.08 | 0 | 0 |
Tax paid | -5.03 | -5.46 | -2.76 | 0 |
Working capital | 5.53 | -0.38 | 25.39 | -0.78 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.59 | 90.37 | 0 | 0 |
Op profit growth | -8.6 | 192.29 | -941.06 | 471.3 |
EBIT growth | -4.12 | 122.43 | -1,303.49 | 478.82 |
Net profit growth | -3.07 | 132.97 | -943.73 | 341.95 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 292.56 | 241.29 | 336.43 | 279.39 | 231.33 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 292.56 | 241.29 | 336.43 | 279.39 | 231.33 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | -3.72 | -2.65 | 2.64 | 4.97 | 2.23 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,655 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,540.1 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,602.4 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,446.6 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Ashish Maheshwari
Non Executive Director
Minoshi Maheshwari
Independent Non Exe. Director
Kunal M Bhakta
Independent Non Exe. Director
Gandhi Gamji
Independent Non Exe. Director
M. Srinivas Rao
Company Sec. & Compli. Officer
Mohith Kumar Khandelwal
41/298-D2 2nd Flr Saniya Plaza,
Mahakavi Bharatiyar Road,
Kerala - 682035
Tel: 91-484-4032952/6596725
Website: http://www.balaxipharma.in
Email: secretarial@anandamrubberco.com
Surya 35 Mayflower,
Avenue Sowripalayam, Road,
Coimbatore - 641 028
Tel: 91-422-4958995/836
Website: www.skdc-consultants.com
Email: info@skdc-consultants.com
Summary
Balaxi Ventures Limited was formerly incorporated in the name of The Anandam Rubber Company Limited on September 28, 1942. The Company changed its name from The Anandam Rubber Company Limited to Balax...
Read More
Reports by Balaxi Pharmaceuticals Ltd
What is the Balaxi Pharmaceuticals Ltd share price today?
What is the Market Cap of Balaxi Pharmaceuticals Ltd?
What is the PE and PB ratio of Balaxi Pharmaceuticals Ltd?
What is the 52 Week High and Low of Balaxi Pharmaceuticals Ltd?
What is the CAGR of Balaxi Pharmaceuticals Ltd?
What is the shareholding pattern of Balaxi Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.